| Report ID |
76396 |
| Drug Identification Number |
02018160 |
| Brand name |
CYCLOMEN |
| Common or Proper name |
Cyclomen |
| Company Name |
SANOFI-AVENTIS CANADA INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
DANAZOL |
| Strength(s) |
200MG |
| Dosage form(s) |
CAPSULE |
| Route of administration |
ORAL |
| Packaging size |
100 |
| ATC code |
G03XA |
| ATC description |
OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM |
| Reason for shortage |
Other (Please describe in comments) |
| Anticipated start date |
2019-03-15 |
| Actual start date |
|
| Estimated end date |
2020-02-17 |
| Actual end date |
2020-02-07 |
| Shortage status |
Resolved |
| Updated date |
2020-02-10 |
| Company comments |
Delay in manufacturing. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. |
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |
